MPH Health Care

Regulatory Filings • Oct 26, 2009

News Details

Corporate | 26 October 2009 21:14

MPH’s subsidiary HAEMATO PHARM AG supports Federal State of Brandenburg in preparation for immunization against the new influenza (so-called swine influenza, Schweinegrippe)

MPH Mittelständische Pharma Holding AG / Miscellaneous

26.10.2009

Dissemination of a Corporate News, transmitted by
DGAP - a company of EquityStory AG.
The issuer / publisher is solely responsible for the content of this announcement.

---

HAEMATO PHARM AG, 100% percent subsidiary of listed MPH Mittelständische
Pharma Holding AG, was mandated by the Federal State of Brandenburg
(ministry responsible for labor, social welfare, health and family) to do
the logistics of the supply of the public health departments respectively
of more than 500 pharmacies within the Federal State of Brandenburg with
sera combating the new influenza virus (H1N1 virus).

This was announced within a common press conference on 23 October 2009.

HAEMATO PHARM AG will repack sera, delivered in bulk packs, and combine
sera with inoculation accessories. After that, inoculation dose rates for
up to 1.5 million vaccinations will be distributed to public health
departments (first 2 to 3 weeks) and then to pharmacies. First lot already
left storage of HAEMATO PHARM AG and arrived at public health departments.
Delivery of sera will take place up to February 2010, presumably.

Patrick Brenske, CEO of MPH Mittelständische Pharma Holding AG:
'That's good news for our shareholders. The mandate given by the Federal
State of Brandenburg shows, that we were able to position our subsidiary
very early as a reliable business partner. Again we see, that HAEMATO PHARM
AG is a very good investment for us.'.

About MPH Mittelständische Pharma Holding AG:

Berlin based MPH Mittelständische Pharma Holding AG is an investment
company within the pharmaceutical/healthcare sector. Core segments are
parallel imports (currently focussing oncology, rheumatology and HIV),
generic medicaments and wholesaling.

Since 1 September 2009, MPH Mittelständische Pharma Holding AG is listed in
the Open Market of Frankfurt stock exchange.

Key figures to the MPH share:

Capital stock EUR 38,050,000
Listed class of shares Bearer preferred share
Number of outstanding preferred shares 19,025,000
ISIN DE000A0NF697
Ticker symbol 93MV
Freefloat 2 percent*
Designated Sponsor Close Brothers Seydler Bank AG

* re-placement of stake of major shareholder Magnum AG in preparation

bonnIR
Hubert Bonn

Phone: +49 (0)6157 9861190
Mailto: bonn@bonn-ir.com

26.10.2009 Financial News transmitted by DGAP

---